Invention Grant
- Patent Title: Compositions and methods for antigen targeting to CD180
-
Application No.: US14426635Application Date: 2013-09-16
-
Publication No.: US10196614B2Publication Date: 2019-02-05
- Inventor: Edward Clark , Jay Wesley Chaplin
- Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
- Applicant Address: US WA Seattle
- Assignee: University of Washington Through its Center for Commercialization
- Current Assignee: University of Washington Through its Center for Commercialization
- Current Assignee Address: US WA Seattle
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2013/059898 WO 20130916
- International Announcement: WO2014/046994 WO 20140327
- Main IPC: A61K47/48
- IPC: A61K47/48 ; C12N7/00 ; A61K39/12 ; A61K39/385 ; C07K16/28 ; A61K39/29 ; A61K47/68 ; A61K39/00
Abstract:
The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
Public/Granted literature
- US20150238630A1 Compositions and Methods for Antigen Targeting to CD180 Public/Granted day:2015-08-27
Information query
